Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations

被引：1
|
作者：
Kubler, Kirsten
Nardone, Agostina
Anand, Shankara
Gorvich, Daniel
Droog, Marjolein
Hermida-Prado, Francisco
Akshi, Tara
Feit, Avery S.
Cohen, Gabriella
Dackus, Gwen
Pun, Matthew
Kuang, Yanan
Cha, Justin
Miller, Mendy
Gibson, William J.
Paweletz, Cloud P.
Van Allen, Eliezer M.
van Leeuwen, Flora E.
Nederlof, Petra
Hollema, Harry
Quang-De Nguyen
Mourits, Marian J. E.
Leshchiner, Ignaty
Stewart, Chip
Matulonis, Ursula A.
Zwart, Wilbert
Maruvka, Yosef E.
Getz, Gad
Jeselsohn, Rinath
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-GS2-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
GS2-09
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PI3K expression and PIK3CA mutations are related to colorectal cancer metastases
    Zhu, Yu-Fen
    Yu, Bao-Hua
    Li, Da-Li
    Ke, Hong-Lin
    Guo, Xian-Zhi
    Xiao, Xiu-Ying
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (28) : 3745 - 3751
  • [2] PI3K expression and PIK3CA mutations are related to colorectal cancer metastases
    Yu-Fen Zhu
    World Journal of Gastroenterology, 2012, (28) : 3745 - 3751
  • [3] Analysis of PIK3CA mutations and PI3K signaling proteins as prognostic biomarkers for advanced gastric cancer
    Nishizuka, Satoshi S.
    Ito, Chie
    Kume, Kohei
    Iwaya, Takeshi
    Koeda, Keisuke
    Sasaki, Akira
    CANCER RESEARCH, 2017, 77
  • [4] Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer
    Ito, Chie
    Nishizuka, Satoshi S.
    Ishida, Kazuyuki
    Uesugi, Noriyuki
    Sugai, Tamotsu
    Tamura, Gen
    Koeda, Keisuke
    Sasaki, Akira
    JOURNAL OF SURGICAL RESEARCH, 2017, 212 : 195 - 204
  • [5] Double PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer
    Vasan, N.
    Razavi, P.
    Johnson, J. L.
    Shao, H.
    Reznik, E.
    Smith, M. L.
    Sebra, R.
    Cantley, L. C.
    Scaltriti, M.
    Baselga, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 1 - 1
  • [6] PIK3CA mutations and response to PI3K and MEK targeted therapies in NSCLC
    Heavey, S.
    Davies, M. A.
    O'Byrne, K. J.
    Gately, K.
    LUNG CANCER, 2013, 79 : S3 - S3
  • [7] PIK3CA Mutations PREDICT RESPONSE TO PI3K/AKT/mTOR INHIBITORS
    不详
    CANCER DISCOVERY, 2012, 2 (03) : 205 - 205
  • [8] PIK3CA and PIK3R1 mutations in cancer: from the mechanism of activation to PI3K targeted therapies
    Rzepecka, Iwona K.
    Tysarowski, Andrzej
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [9] Activation of the PI3K/AKT pathway and PIK3CA mutations in Merkel cell carcinoma
    Hafner, C.
    Houben, R.
    Baeurle, A.
    Landthaler, M.
    Becker, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2010, 8 (09): : 739 - 739
  • [10] Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
    Vasan, Neil
    Razavi, Pedram
    Johnson, Jared L.
    Shao, Hong
    Shah, Hardik
    Antoine, Alesia
    Ladewig, Erik
    Gorelick, Alexander
    Lin, Ting-Yu
    Toska, Eneda
    Xu, Guotai
    Kazmi, Abiha
    Chang, Matthew T.
    Taylor, Barry S.
    Dickler, Maura N.
    Jhaveri, Komal
    Chandarlapaty, Sarat
    Rabadan, Raul
    Reznik, Ed
    Smith, Melissa L.
    Sebra, Robert
    Schimmoller, Frauke
    Wilson, Timothy R.
    Friedman, Lori S.
    Cantley, Lewis C.
    Scaltriti, Maurizio
    Baselga, Jose
    CANCER RESEARCH, 2020, 80 (16)
12345